Why the study?
This 2017 update introduces an adapted ESC Guideline format alongside companion ESC Textbook chapters to provide both concise summaries of available evidence and in-depth reviews for managing valvular heart disease.
Provides the 2017 ESC/EACTS Guidelines for the management of Valvular Heart Disease and Peripheral Arterial Diseases.
Answers are grounded in this paper and cite their sources.
Updates valvular heart disease and peripheral arterial disease standards; extends synthesized evidence into clinical practice and trial design.
in Barcelona, namely the 2017 ESC/EACTS Guidelines for the management of Valvular Heart Disease and the 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases.More documents will follow along this pathway of development in the future.The ESC CPG, in collaboration with the GECEP, will carefully monitor the process and implementation over the coming months.We are hopeful that these changes will enhance the knowledge and educational value along the principle of the Virtuous Cycle, outlined in the following article by Alec Vahanian, by providing both concise, state-of-the art summaries of available evidence in the adapted ESC Guideline format and in-depth reviews in the companion ESC Textbook chapters.Access to the ESC Guidelines will continue to be free of charge via www.escardio.org/guidelines.
No takes yet. Share an insight, caveat, or question.
Judith Ozkan (2017) conducted an editorial in Valvular Heart Disease. The 2017 ESC/EACTS Guidelines for the management of Valvular Heart Disease provide concise summaries of available evidence alongside companion ESC Textbook chapters.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: